Company Data
Anebulo Pharmaceuticals Inc.
Ticker
ANEB
Current Price
$0.315 -4.55%
Market Cap
$12.8M
Price Target
Refer to Report
Volume
115
52wk Range
$0.0004 - $2.85
Overview
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.